PROCEPT BioRobotics Corporation
US ˙ NasdaqGM ˙ US74276L1052

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for CPMG Inc. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at CPMG Inc har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:PRCT / PROCEPT BioRobotics Corporation 10% Owner 2 823 681
US:RETA / Reata Pharmaceuticals Inc - Class A Director, 10% Owner 0
US:APEN / Apollo Endosurgery Inc 10% Owner 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av CPMG Inc. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp PRCT / PROCEPT BioRobotics Corporation - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i PRCT / PROCEPT BioRobotics Corporation. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
2021-09-17 PRCT CPMG Inc 440 000 25,0000 440 000 25,0000 11 000 000 357 50.6500 11 286 000 102,60

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

PRCT / PROCEPT BioRobotics Corporation Insider Trades
Internhandel PRCT / PROCEPT BioRobotics Corporation - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i PRCT / PROCEPT BioRobotics Corporation. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

PRCT / PROCEPT BioRobotics Corporation Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av CPMG Inc som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2024-05-07 2024-05-03 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other −1 785 127 2 823 681 −38,73
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −134 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −11 076 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −160 265 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −334 740 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −37 909 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −109 415 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −431 155 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −748 253 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −442 560 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −34 897 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −44 200 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −5 464 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −137 962 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −282 246 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −116 512 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −113 0 −100,00
2023-09-28 2023-09-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
D - Sale to Issuer −31 467 0 −100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer −400 675 0 −100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer −63 671 0 −100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer −45 594 0 −100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer −3 687 781 0 −100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer −1 310 701 0 −100,00
2023-04-04 2023-04-04 4 APEN Apollo Endosurgery, Inc.
Common Stock
D - Sale to Issuer −675 181 0 −100,00
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 1 465 770 3 687 781 65,97 3,25 4 763 752 11 985 288
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 586 308 1 310 701 80,94 3,25 1 905 501 4 259 778
2022-12-30 2022-12-28 4 APEN Apollo Endosurgery, Inc.
Class A common stock
C - Conversion 146 577 675 181 27,73 3,25 476 375 2 194 338
2022-12-07 2022-12-05 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other −1 726 534 5 029 869 −25,55
2022-11-16 2022-11-14 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other −1 729 482 6 993 137 −19,83
2022-09-13 2022-09-09 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other −986 640 8 955 675 −9,92
2022-09-08 2022-09-06 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other −743 021 10 075 491 −6,87
2022-03-21 2022-03-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
J - Other −304 268 10 918 394 −2,71
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 387 097 2 151 209 21,94 7,75 3 000 002 16 671 870
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 258 064 696 071 58,92 7,75 1 999 996 5 394 550
2021-10-19 2021-10-15 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 38 710 521 522 8,02 7,75 300 002 4 041 796
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series G Convertible Preferred Stock
C - Conversion −272 205 0 −100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series F Convertible Preferred Stock
C - Conversion −2 060 802 0 −100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series E Convertible Preferred Stock
C - Conversion −3 038 934 0 −100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Series D Convertible Preferred Stock
C - Conversion −4 712 969 0 −100,00
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
P - Purchase 440 000 11 222 662 4,08 25,00 11 000 000 280 566 550
2021-09-21 2021-09-17 4 PRCT PROCEPT BioRobotics Corp
Common Stock
C - Conversion 10 084 910 10 782 662 1 445,34
2021-09-14 3 PRCT PROCEPT BioRobotics Corp
Common Stock
697 752
2020-12-29 2020-12-23 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
J - Other −103 185 0 −100,00
2020-12-29 2020-12-23 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
J - Other −63 481 0 −100,00
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 1 200 000 1 707 208 236,59 1,25 1 500 000 2 134 010
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 400 000 415 244 2 623,98 1,25 500 000 519 055
2020-07-21 2020-07-17 4 APEN Apollo Endosurgery, Inc.
Class A common stock
P - Purchase 180 000 477 120 60,58 1,25 225 000 596 400
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 38 108 507 208 8,12
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 15 244 15 244
2020-01-06 2020-01-02 4 APEN Apollo Endosurgery, Inc.
Class A common stock
J - Other 3 811 297 120 1,30
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5 464 5 464 183,00 999 912 999 912
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 27 322 137 962 24,69 183,00 4 999 926 25 247 046
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 328 282 246 0,12 183,00 60 024 51 651 018
2019-11-18 2019-11-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 7 104 116 512 6,49 183,00 1 300 032 21 321 696
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 317 943
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 565 658
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 336 020
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 673 024
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 741 449
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 317 943
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 565 658
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 336 020
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 673 024
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 741 449
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 317 943
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 565 658
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 336 020
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 673 024
2019-08-22 3 APEN Apollo Endosurgery, Inc.
Common Stock
1 741 449
2018-12-12 2018-12-12 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 418 281 918 0,51 59,90 84 931 16 885 535
2018-12-12 2018-12-11 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 52 809 109 408 93,30 60,07 3 172 337 6 572 346
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 29 347 56 599 107,69 59,53 1 747 036 3 369 355
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 078 27 252 4,12 58,62 63 194 1 597 561
2018-12-12 2018-12-10 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 26 174 26 174 57,93 1 516 336 1 516 336
2017-12-29 2017-12-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 17 000 44 200 62,50 28,47 484 016 1 258 440
2017-12-28 2017-12-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 200 27 200 0,74 26,10 5 220 709 920
2017-12-28 2017-12-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 15 000 27 000 125,00 25,83 387 444 697 399
2017-12-28 2017-12-26 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 12 000 12 000 26,06 312 726 312 726
2017-12-28 2017-12-14 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14 866 34 897 74,21 24,65 366 489 860 309
2017-12-28 2017-12-13 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 49 20 031 0,25 23,98 1 175 480 277
2017-12-28 2017-12-13 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19 982 19 982 24,88 497 228 497 228
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 37 492 431 155 9,52 24,65 924 283 10 629 178
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6 245 103 185 6,44 24,65 153 957 2 543 799
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19 672 748 253 2,70 24,65 484 970 18 446 532
2017-12-15 2017-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14 866 477 457 3,21 24,65 366 489 11 770 652
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 148 393 663 0,04 23,98 3 549 9 438 740
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 59 982 393 515 17,98 24,88 1 492 580 9 792 149
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 25 96 940 0,03 23,98 599 2 324 301
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 9 990 96 915 11,49 24,88 248 589 2 411 613
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 78 728 581 0,01 23,98 1 870 17 468 968
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 31 471 728 503 4,52 24,88 783 118 18 127 923
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 49 462 591 0,01 23,98 1 175 11 091 406
2017-12-15 2017-12-13 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19 982 462 542 4,52 24,88 497 228 11 509 803
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion −110 640 0 −100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion −33 656 0 −100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion −386 285 0 −100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
C - Conversion −211 708 0 −100,00
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 110 640 110 640 25,00 2 766 000 2 766 000
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 33 656 33 656 25,00 841 400 841 400
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 386 285 386 285 25,00 9 657 125 9 657 125
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 211 708 211 708 25,00 5 292 700 5 292 700
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 355 591 993 929 55,71 25,00 8 889 775 24 848 225
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class B Common Stock
P - Purchase 102 120 114 946 796,20 25,00 2 553 000 2 873 650
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 110 640 110 640
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 33 656 86 925 63,18
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 386 285 697 032 124,31
2017-06-23 2017-06-22 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 211 708 442 560 91,71
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 510 334 740 0,76 21,72 54 529 7 272 126
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 810 310 747 0,91 21,72 61 046 6 750 885
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 730 230 852 0,76 21,72 37 584 5 015 190
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 480 63 481 0,76 21,72 10 428 1 379 106
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 220 37 909 0,58 21,72 4 779 823 562
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 512 333 533 0,15 21,72 11 123 7 245 904
2017-01-04 2016-12-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 130 109 415 1,04 21,72 24 549 2 377 008
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 42 110 332 230 14,51 22,99 968 147 7 638 267
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 64 250 307 937 26,37 22,99 1 477 165 7 079 749
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 29 040 229 122 14,51 22,99 667 656 5 267 721
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 7 990 63 001 14,52 22,99 183 697 1 448 450
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 330 37 689 3,66 22,99 30 578 866 504
2016-12-20 2016-12-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 20 033 280 500 7,69 22,99 460 577 6 448 947
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 579 290 120 0,20 22,05 12 767 6 397 088
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 290 243 687 0,53 22,05 28 444 5 373 250
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 400 200 082 0,20 22,05 8 820 4 411 768
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 110 55 011 0,20 22,05 2 425 1 212 982
2016-12-16 2016-12-15 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 321 260 467 0,12 22,05 7 078 5 743 245
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 439 289 541 0,50 21,37 30 744 6 186 072
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 810 242 397 1,17 21,37 60 036 5 178 836
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 000 199 682 0,50 21,37 21 365 4 266 226
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 270 54 901 0,49 21,37 5 769 1 172 965
2016-12-16 2016-12-14 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 670 260 146 0,26 21,37 14 315 5 558 045
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 34 130 288 102 13,44 17,32 591 234 4 990 791
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 35 490 239 587 17,39 17,32 614 793 4 150 366
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23 530 198 682 13,43 17,32 407 610 3 441 768
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4 120 108 285 3,96 17,32 71 371 1 875 821
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6 470 54 631 13,43 17,32 112 080 946 373
2016-08-18 2016-08-18 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 822 36 359 5,28 17,32 31 563 629 847
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 46 510 253 972 22,42 17,26 802 884 4 384 217
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 48 320 204 097 31,02 17,26 834 129 3 523 245
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 32 080 175 152 22,42 17,26 553 784 3 023 579
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5 830 104 165 5,93 17,26 100 641 1 798 159
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8 820 48 161 22,42 17,26 152 256 831 384
2016-08-18 2016-08-17 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 498 34 537 7,80 17,26 43 122 596 198
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 18 620 207 462 9,86 16,21 301 845 3 363 125
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 19 050 155 777 13,93 16,21 308 816 2 525 270
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 12 840 143 072 9,86 16,21 208 147 2 319 312
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 460 98 335 3,65 16,21 56 089 1 594 089
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 530 39 341 9,86 16,21 57 224 637 749
2016-08-18 2016-08-16 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 100 32 039 3,56 16,21 17 832 519 378
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 99 922 99 922 11,00 1 099 142 1 099 142
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 72 357 72 357 11,00 795 927 795 927
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 68 912 68 912 11,00 758 032 758 032
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 18 951 18 951 11,00 208 461 208 461
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 16 366 16 366 11,00 180 026 180 026
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 53 119 53 119 11,00 584 309 584 309
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 275 047 332 396 479,60 11,00 3 025 517 3 656 356
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 64 712 78 205 479,60 11,00 711 832 860 255
2016-08-09 2016-06-01 4/A RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 132 614 160 265 479,60 11,00 1 458 754 1 762 915
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 34 010 88 920 61,94 19,75 671 735 1 756 268
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 24 630 64 370 61,98 19,75 486 470 1 271 378
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23 460 61 320 61,97 19,75 463 361 1 211 137
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5 880 30 163 24,21 19,75 116 136 595 752
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6 450 16 860 61,96 19,75 127 395 333 004
2016-06-30 2016-06-30 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5 570 14 573 61,87 19,75 110 014 287 833
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 21 690 54 910 65,29 19,83 430 074 1 088 766
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 15 700 39 740 65,31 19,83 311 303 787 973
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14 960 37 860 65,33 19,83 296 630 750 696
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 690 24 283 17,92 19,83 73 166 481 488
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4 110 10 410 65,24 19,83 81 494 206 412
2016-06-30 2016-06-29 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 550 9 003 65,10 19,83 70 390 178 513
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 310 33 220 0,94 19,74 6 119 655 670
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 220 24 040 0,92 19,74 4 342 474 482
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 210 22 900 0,93 19,74 4 145 451 982
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 50 20 593 0,24 19,74 987 406 448
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 50 20 593 0,24 19,74 987 406 448
2016-06-30 2016-06-28 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 60 6 300 0,96 19,74 1 184 124 344
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6 770 259 476 2,68 19,17 129 814 4 975 426
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 5 130 32 190 18,96 19,17 98 367 617 240
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 720 23 820 18,51 19,17 71 331 456 746
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 540 22 690 18,49 19,17 67 879 435 078
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 990 20 543 5,06 19,17 18 983 393 910
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 970 6 240 18,41 19,17 18 600 119 651
2016-06-28 2016-06-27 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 848 5 403 18,62 19,17 16 260 103 602
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 14 386 27 780 107,41 19,49 280 390 541 446
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 10 418 20 100 107,60 19,49 203 052 391 759
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 9 921 19 150 107,50 19,49 193 365 373 243
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 712 19 553 16,10 19,49 52 858 381 098
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 728 5 270 107,32 19,49 53 170 102 715
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 360 4 555 107,52 19,49 45 998 88 779
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 3 014 13 394 29,04 18,35 55 307 245 781
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 182 9 682 29,09 18,35 40 040 177 666
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 079 9 229 29,08 18,35 38 150 169 353
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 568 16 841 3,49 18,35 10 423 309 034
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 572 2 542 29,04 18,35 10 496 46 646
2016-06-28 2016-06-24 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 495 2 195 29,12 18,35 9 083 40 278
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 400 10 380 15,59 17,62 24 669 182 905
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 010 7 500 15,56 17,62 17 797 132 157
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 970 7 150 15,70 17,62 17 092 125 989
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 340 16 273 2,13 17,62 5 991 286 745
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 270 1 970 15,88 17,62 4 758 34 713
2016-06-08 2016-06-07 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 230 1 700 15,65 17,62 4 053 29 956
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6 650 8 980 285,41 17,56 116 771 157 685
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4 810 6 490 286,31 17,56 84 462 113 962
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 4 580 6 180 286,25 17,56 80 423 108 518
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 610 15 933 11,24 17,56 28 271 279 777
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 260 1 700 286,36 17,56 22 125 29 851
2016-06-08 2016-06-06 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 090 1 470 286,84 17,56 19 140 25 813
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 625 57 974 1,09 13,42 8 387 778 005
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 830 14 323 6,15 13,42 11 139 192 213
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 2 330 2 330 13,42 31 268 31 268
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 680 1 680 13,42 22 545 22 545
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 1 600 1 600 13,42 21 472 21 472
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 440 440 13,42 5 905 5 905
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 380 380 13,42 5 100 5 100
2016-06-03 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 150 150 13,42 2 013 2 013
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −134 1 490 −8,25
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −57 349 638 338 −8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −13 493 150 186 −8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −11 076 123 279 −8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −1 153 12 826 −8,25
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −27 651 307 776 −8,24
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class B common stock
C - Conversion −113 1 251 −8,28
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 23 890 252 706 10,44 14,11 336 997 3 564 721
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 6 203 228 816 2,79 14,22 88 218 3 254 198
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 28 797 222 613 14,86 13,26 381 989 2 952 939
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 8 233 193 816 4,44 13,22 108 815 2 561 647
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 127 691 185 583 220,57 12,76 1 629 899 2 368 856
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
P - Purchase 56 739 57 892 4 920,99 11,43 648 305 661 480
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 134 134
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 57 349 57 349
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 13 493 13 493
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 11 076 11 076
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 1 153 1 153
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 27 651 27 651
2016-06-01 2016-06-01 4 RETA REATA PHARMACEUTICALS INC
Class A common stock
C - Conversion 113 113
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)